Inflammatory Markers and the Metabolic Syndrome
- 9 November 2005
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 46 (11), 1978-1985
- https://doi.org/10.1016/j.jacc.2005.06.082
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 DiabetesHypertension, 2005
- Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic SyndromeJAMA, 2004
- Simvastatin Combined With Ramipril Treatment in Hypercholesterolemic PatientsHypertension, 2004
- Vascular effects of diet and statin in hypercholesterolemic patientsInternational Journal of Cardiology, 2004
- Comparison of effects of losartan, irbesartan, and candesartan on flow-mediated brachial artery dilation and on inflammatory and thrombolytic markers in patients with systemic hypertensionThe American Journal of Cardiology, 2004
- Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular eventsCurrent Opinion in Cardiology, 2003
- Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential HypertensionHypertension, 2003
- Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery DiseaseCirculation, 2003
- Accumulation of LDL in Rat Arteries Is Associated With Activation of Tumor Necrosis Factor-α ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999